GL1X · GenesisL1 explorer

Research workbench

Human androgen receptor in complex with AF2 small molecule inhibitor

Analyse Human androgen receptor in complex with AF2 small molecule inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2YHD
Type
protein
Length
249 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Androgen receptor
UniProt
P10275
Ligands
TES, AV6, SO4
Pockets
2 · best druggability 0.83

Structure

x-ray diffraction · 1 distinct chain · 66% helix, 5% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAndrogen receptorprotein24966% helix, 5% strandP10275

Ligands and binding sites

  • TES · Testosterone · ligand · chains A
  • AV6 · 4-(2,3-dihydro-1H-perimidin-2-yl)benzene-1,2-diol · ligand · chains A
  • SO4 · Sulfate ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11730.830.9721TES
21260.650.8821empty

Compared structures

  • 2YHD · Human androgen receptor in complex with AF2 small molecule inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • P10275 · AlphaFold monomer V2.0 prediction for androgen receptor (P10275) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.